(资料图)
南方财经5月29日电，中国生物制药公告，当日受托人从市场进一步购买1200万股股份，并根据计划规则的条款及条件代获选参与者以信托持有。每股股份平均代价约3.83港元，购买股份总代价约4596万港元。
(资料图)
南方财经5月29日电，中国生物制药公告，当日受托人从市场进一步购买1200万股股份，并根据计划规则的条款及条件代获选参与者以信托持有。每股股份平均代价约3.83港元，购买股份总代价约4596万港元。
2023-05-30
2023-05-29
2023-05-29
2023-05-29
2023-05-29
2023-05-29
2023-05-29
2023-05-29
2023-05-29
2023-05-29
2023-05-29
2023-05-29
2023-05-29
2023-05-29
2023-05-29
2023-05-29
2023-05-29
2023-05-29
2023-05-29
2023-05-29
2023-05-29
2023-05-29
2023-05-29
2023-05-29
2023-05-29
2023-05-29
2023-05-29
2023-05-28
2023-05-28
2023-05-28
2023-05-28
2023-05-28
2023-05-28
2023-05-28
2023-05-28
2023-05-28
2023-05-28
2023-05-28
2023-05-28
2023-05-28
2023-05-28
2023-05-28
2023-05-28
2023-05-28
2023-05-28
2023-05-28
2023-05-28
2023-05-27
2023-05-27
2023-05-27
2023-05-27
2023-05-27
2023-05-27
2023-05-27
2023-05-27
2023-05-27
2023-05-27
2023-05-27
2023-05-27
2023-05-27
2023-05-27
2023-05-27
2023-05-27
2023-05-27
2023-05-27
2023-05-27
2023-05-27
2023-05-27
2023-05-27
2023-05-27
2023-05-27
2023-05-26
2023-05-26
2023-05-26
2023-05-26
2023-05-26
2023-05-26
2023-05-26
2023-05-26
2023-05-26
2023-05-26
2023-05-26
2023-05-26
2023-05-26
2023-05-26
2023-05-26
2023-05-26
2023-05-26
2023-05-26
2023-05-26
2023-05-26
2023-05-26
2023-05-26
2023-05-26
2023-05-26
2023-05-26
2023-05-26
2023-05-26
2023-05-26
2023-05-26